These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 23246510

  • 21. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
    Mitterreiter JG, Titulaer MJ, van Nierop GP, van Kampen JJ, Aron GI, Osterhaus AD, Verjans GM, Ouwendijk WJ.
    PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
    [Abstract] [Full Text] [Related]

  • 22. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
    Shiraki K, Ogino T, Yamanishi K, Takahashi M.
    Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
    Nugier F, Colin JN, Aymard M, Langlois M.
    J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of mutations on herpes simplex virus 1 thymidine kinase functionality: an in vitro assay based on detection of monophosphate forms of acyclovir and thymidine using HPLC/DAD.
    Malartre N, Boulieu R, Falah N, Cortay JC, Lina B, Morfin F, Frobert E.
    Antiviral Res; 2012 Sep; 95(3):224-8. PubMed ID: 22796575
    [Abstract] [Full Text] [Related]

  • 27. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
    van Velzen M, van de Vijver DA, van Loenen FB, Osterhaus AD, Remeijer L, Verjans GM.
    J Infect Dis; 2013 Nov 01; 208(9):1359-65. PubMed ID: 23901090
    [Abstract] [Full Text] [Related]

  • 28. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
    Burrel S, Aime C, Hermet L, Ait-Arkoub Z, Agut H, Boutolleau D.
    Antiviral Res; 2013 Nov 01; 100(2):365-72. PubMed ID: 24075863
    [Abstract] [Full Text] [Related]

  • 29. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
    Inagaki T, Satoh M, Fujii H, Yamada S, Shibamura M, Yoshikawa T, Harada S, Takeyama H, Saijo M.
    Jpn J Infect Dis; 2018 Sep 21; 71(5):343-349. PubMed ID: 29848849
    [Abstract] [Full Text] [Related]

  • 30. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE.
    J Clin Virol; 2013 Sep 21; 58(1):321-4. PubMed ID: 23731845
    [Abstract] [Full Text] [Related]

  • 31. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
    Stránská R, van Loon AM, Bredius RG, Polman M, Nienhuis E, Beersma MF, Lankester AC, Schuurman R.
    Antivir Ther; 2004 Feb 21; 9(1):97-104. PubMed ID: 15040541
    [Abstract] [Full Text] [Related]

  • 32. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
    Shimada Y, Suzuki M, Shirasaki F, Saito E, Sogo K, Hasegawa M, Takehara K, Phromjai J, Chuhjo T, Shiraki K.
    J Med Virol; 2007 Nov 21; 79(11):1731-40. PubMed ID: 17854045
    [Abstract] [Full Text] [Related]

  • 33. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R, de Vries RD, Osterhaus AD, Remeijer L, Verjans GM.
    J Infect Dis; 2008 Sep 01; 198(5):659-63. PubMed ID: 18627246
    [Abstract] [Full Text] [Related]

  • 34. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.
    Sarisky RT, Cano R, Nguyen TT, Wittrock RJ, Duffy KE, Clark P, Bartus JO, Bacon TH, Caspers-Velu L, Hodinka RL, Leary JJ.
    Clin Infect Dis; 2001 Dec 15; 33(12):2034-9. PubMed ID: 11712095
    [Abstract] [Full Text] [Related]

  • 35. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
    Shin YK, Cai GY, Weinberg A, Leary JJ, Levin MJ.
    J Clin Microbiol; 2001 Mar 15; 39(3):913-7. PubMed ID: 11230403
    [Abstract] [Full Text] [Related]

  • 36. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O, Barbani MT, Klenja S, Morfin F, Frobert E, Gorgievski M, Steinlin-Schopfer J, Suter-Riniker F.
    J Clin Virol; 2020 Apr 15; 125():104303. PubMed ID: 32163870
    [Abstract] [Full Text] [Related]

  • 37. CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation.
    Zheng S, Verjans GMGM, Evers A, van den Wittenboer E, Tjhie JHT, Snoeck R, Wiertz EJHJ, Andrei G, van Kampen JJA, Lebbink RJ.
    Antiviral Res; 2024 Aug 15; 228():105950. PubMed ID: 38944159
    [Abstract] [Full Text] [Related]

  • 38. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K.
    J Med Virol; 2001 Jan 15; 63(1):57-63. PubMed ID: 11130888
    [Abstract] [Full Text] [Related]

  • 39. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
    Nitta K, Shiota H, Naito T, Mimura Y.
    Nippon Ganka Gakkai Zasshi; 1994 Jun 15; 98(6):513-9. PubMed ID: 8030564
    [Abstract] [Full Text] [Related]

  • 40. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
    Gaudreau A, Hill E, Balfour HH, Erice A, Boivin G.
    J Infect Dis; 1998 Aug 15; 178(2):297-303. PubMed ID: 9697707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.